Mindray chairman boosts stake, plans further investment

Li Xiting, chairman of Shenzhen Mindray Bio-Medical Electronics, executed an initial share purchase on November 27, 2025, acquiring 152,340 shares at an average price of 196.862 yuan per share, totaling 29,989,930.80 yuan. This transaction marks his first direct ownership in the company. Prior to this, Li, along with his concert parties, indirectly controlled 51.47% of the company's shares. Following the increase, his direct and indirect control collectively stands at 51.48%.

Furthermore, Li announced a plan to increase his stake by an additional 200 million yuan (including transaction fees and the value of the initial increase) within six months starting November 27, 2025. The open market purchases will be funded by his own capital and will not have a fixed price range, adapting to market conditions. The shares acquired under this plan will be subject to a six-month lock-up period post-completion.

The plan is driven by confidence in the company's intrinsic value and future growth prospects, aiming to support the high-quality development of the capital market. Li committed to adhering to relevant regulations and pledges not to reduce his shareholding during the increase period and the statutory period.